Iodide

Iodide

SCHEMBL28416673

I.O=CCCP(c1ccccc1)c1ccccc1

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ADH1B P00325 1/20 0.34
ADH1C P00326 1/20 0.34
ADH1A P07327 1/20 0.34
ADH7 P40394 1/20 0.34
AOX1 Q06278 1/20 0.33
ALDH1A1 P00352 1/20 0.32
CYP2A6 P11509 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1038657 0.98 CYP3A4 (0.36) CYP3A4TDP1ADH1BADH1CADH1A
SCHEMBL11550852 0.85 HIF1A (0.36) CYP3A4TDP1ADH1BADH1CADH1A
SCHEMBL22458131 0.83 HIF1A (0.35) CYP3A4TDP1ADH1BADH1CADH1A
SCHEMBL18845437 0.82 TSHR (0.35) CYP3A4TDP1ADH1BADH1CADH1A
SCHEMBL4749847 0.76 CYP3A4 (0.36) CYP3A4TDP1ALDH1A1
SCHEMBL27343 0.75 CYP3A4 (0.50) CYP3A4TDP1ALDH1A1
SCHEMBL6349486 0.75 TDP1 (0.39) CYP3A4TDP1ADH1BADH1CADH1A
Phosphine SCHEMBL25423478 0.73 CYP3A4 (0.47) CYP3A4TDP1ALDH1A1
SCHEMBL5075553 0.73 CYP3A4 (0.47) CYP3A4TDP1ALDH1A1
SCHEMBL22749137 0.73 CYP3A4 (0.47) CYP3A4TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111148750-A Azithromycin derivatives containing phosphonium ions as anticancer agents 来兴泰德基金会 2020-05-12 CN disclosed